Compare EXTR & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXTR | ATRC |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 1999 | 2005 |
| Metric | EXTR | ATRC |
|---|---|---|
| Price | $14.34 | $29.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $21.20 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.5M | 720.8K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | 74.74 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $1,140,067,000.00 | $201,630,000.00 |
| Revenue This Year | $13.15 | $15.17 |
| Revenue Next Year | $7.52 | $12.42 |
| P/E Ratio | $142.60 | ★ N/A |
| Revenue Growth | 2.05 | ★ 15.40 |
| 52 Week Low | $10.11 | $28.32 |
| 52 Week High | $22.89 | $43.18 |
| Indicator | EXTR | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 32.58 |
| Support Level | $13.97 | $28.64 |
| Resistance Level | $14.72 | $32.85 |
| Average True Range (ATR) | 0.44 | 1.26 |
| MACD | 0.09 | 0.07 |
| Stochastic Oscillator | 65.08 | 26.81 |
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.